129 related articles for article (PubMed ID: 25534208)
1. ESRD from lupus nephritis in the United States, 1995-2010.
Sexton DJ; Reule S; Solid C; Chen SC; Collins AJ; Foley RN
Clin J Am Soc Nephrol; 2015 Feb; 10(2):251-9. PubMed ID: 25534208
[TBL] [Abstract][Full Text] [Related]
2. Racial and Ethnic Differences in Mortality and Cardiovascular Events Among Patients With End-Stage Renal Disease Due to Lupus Nephritis.
Gómez-Puerta JA; Feldman CH; Alarcón GS; Guan H; Winkelmayer WC; Costenbader KH
Arthritis Care Res (Hoboken); 2015 Oct; 67(10):1453-62. PubMed ID: 25624071
[TBL] [Abstract][Full Text] [Related]
3. Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States.
Devlin A; Waikar SS; Solomon DH; Lu B; Shaykevich T; Alarcón GS; Winkelmayer WC; Costenbader KH
Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1642-53. PubMed ID: 22058067
[TBL] [Abstract][Full Text] [Related]
4. Patient characteristics and outcomes by GN subtype in ESRD.
O'Shaughnessy MM; Montez-Rath ME; Lafayette RA; Winkelmayer WC
Clin J Am Soc Nephrol; 2015 Jul; 10(7):1170-8. PubMed ID: 26092830
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular and cerebrovascular morbidity and mortality among women with end-stage renal disease attributable to lupus nephritis.
Ward MM
Am J Kidney Dis; 2000 Sep; 36(3):516-25. PubMed ID: 10977783
[TBL] [Abstract][Full Text] [Related]
6. Risk of end-stage renal disease in systemic lupus erythematosus patients: a nationwide population-based study.
Yu KH; Kuo CF; Chou IJ; Chiou MJ; See LC
Int J Rheum Dis; 2016 Nov; 19(11):1175-1182. PubMed ID: 26864331
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of renal transplantation among patients with end-stage renal disease caused by lupus nephritis.
Ward MM
Kidney Int; 2000 May; 57(5):2136-43. PubMed ID: 10792635
[TBL] [Abstract][Full Text] [Related]
8. Racial Disparities in Access to and Outcomes of Kidney Transplantation in Children, Adolescents, and Young Adults: Results From the ESPN/ERA-EDTA (European Society of Pediatric Nephrology/European Renal Association-European Dialysis and Transplant Association) Registry.
Tjaden LA; Noordzij M; van Stralen KJ; Kuehni CE; Raes A; Cornelissen EA; O'Brien C; Papachristou F; Schaefer F; Groothoff JW; Jager KJ;
Am J Kidney Dis; 2016 Feb; 67(2):293-301. PubMed ID: 26561356
[TBL] [Abstract][Full Text] [Related]
9. ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010.
Reule S; Sexton DJ; Solid CA; Chen SC; Collins AJ; Foley RN
Am J Kidney Dis; 2014 Oct; 64(4):592-9. PubMed ID: 25134777
[TBL] [Abstract][Full Text] [Related]
10. Changes in the incidence of endstage renal disease due to lupus nephritis in the United States, 1996-2004.
Ward MM
J Rheumatol; 2009 Jan; 36(1):63-7. PubMed ID: 19004042
[TBL] [Abstract][Full Text] [Related]
11. End-stage renal disease due to lupus nephritis among children in the US, 1995-2006.
Hiraki LT; Lu B; Alexander SR; Shaykevich T; Alarcón GS; Solomon DH; Winkelmayer WC; Costenbader KH
Arthritis Rheum; 2011 Jul; 63(7):1988-97. PubMed ID: 21445963
[TBL] [Abstract][Full Text] [Related]
12. Effect of renal disease on the standardized mortality ratio and life expectancy of patients with systemic lupus erythematosus.
Mok CC; Kwok RC; Yip PS
Arthritis Rheum; 2013 Aug; 65(8):2154-60. PubMed ID: 23754671
[TBL] [Abstract][Full Text] [Related]
13. Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006.
Costenbader KH; Desai A; Alarcón GS; Hiraki LT; Shaykevich T; Brookhart MA; Massarotti E; Lu B; Solomon DH; Winkelmayer WC
Arthritis Rheum; 2011 Jun; 63(6):1681-8. PubMed ID: 21445962
[TBL] [Abstract][Full Text] [Related]
14. Racial difference in the prognosis of lupus nephritis.
Mok CC
Nephrology (Carlton); 2010 Jun; 15(4):480-1. PubMed ID: 20609102
[No Abstract] [Full Text] [Related]
15. Remission of proteinuria indicates good prognosis in patients with diffuse proliferative lupus nephritis.
Koo HS; Kim S; Chin HJ
Lupus; 2016 Jan; 25(1):3-11. PubMed ID: 26159540
[TBL] [Abstract][Full Text] [Related]
16. ESKD, Transplantation, and Dialysis in Lupus Nephritis.
Sabucedo AJ; Contreras G
Semin Nephrol; 2015 Sep; 35(5):500-8. PubMed ID: 26573552
[TBL] [Abstract][Full Text] [Related]
17. Changes in Excess Mortality from End Stage Renal Disease in the United States from 1995 to 2013.
Foster BJ; Mitsnefes MM; Dahhou M; Zhang X; Laskin BL
Clin J Am Soc Nephrol; 2018 Jan; 13(1):91-99. PubMed ID: 29242373
[TBL] [Abstract][Full Text] [Related]
18. Sociodemographic and geographic predictors of quality of care in United States patients with end-stage renal disease due to lupus nephritis.
Plantinga LC; Drenkard C; Patzer RE; Klein M; Kramer MR; Pastan S; Lim SS; McClellan WM
Arthritis Rheumatol; 2015 Mar; 67(3):761-72. PubMed ID: 25692867
[TBL] [Abstract][Full Text] [Related]
19. Association of time to kidney transplantation with graft failure among U.S. patients with end-stage renal disease due to lupus nephritis.
Plantinga LC; Patzer RE; Drenkard C; Kramer MR; Klein M; Lim SS; McClellan WM; Pastan SO
Arthritis Care Res (Hoboken); 2015 Apr; 67(4):571-81. PubMed ID: 25251922
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for systemic lupus erythematosus flares in patients with end-stage renal disease: a case-control study.
Barrera-Vargas A; Quintanar-Martínez M; Merayo-Chalico J; Alcocer-Varela J; Gómez-Martín D
Rheumatology (Oxford); 2016 Mar; 55(3):429-35. PubMed ID: 26396262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
